Cargando…

CSF3R T618I mutated chronic myelomonocytic leukemia: A proliferative subtype with a distinct mutational profile

Chronic myelomonocytic leukemia (CMML) is a clonal myeloid neoplasm characterized by sustained monocytosis and mutations in TET2, ASXL1, SRSF2, SETBP1, NRAS, and KRAS. We describe a rare case of CSF3R T618I mutated CMML that has a proliferative phenotype, myelodysplasia, and additional mutations in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Adelaide, Ibrahim, Ibrahim, Le, Tri, Jaso, Jesse Manuel, Weinberg, Olga, Fuda, Franklin, Chen, Weina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108757/ https://www.ncbi.nlm.nih.gov/pubmed/35586707 http://dx.doi.org/10.1016/j.lrr.2022.100323

Ejemplares similares

CSF3R T618I mutant chronic myelomonocytic leukemia (CMML) defines a proliferative CMML subtype enriched in ASXL1 mutations with adverse outcomes
por: Bezerra, Evandro D., et al.
Publicado: (2021)

Myeloid Disease with the CSF3R T618I Mutation after CLL
por: Couto, Maria Eduarda, et al.
Publicado: (2020)

T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation
por: Lee, Sung-Eun, et al.
Publicado: (2015)

Anti-inflammatory effects of ruxolitinib on chronic neutrophilic leukemia harboring CSF3R-T618I mutation with bilateral renal abscesses
por: Sahara, Naohi, et al.
Publicado: (2022)

Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia
por: Ouyang, Yuan, et al.
Publicado: (2017)

Novel splicing-factor mutations in juvenile myelomonocytic leukemia
por: Takita, J, et al.
Publicado: (2012)

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Chesnais, Virginie, et al.
Publicado: (2012)

Mutational landscape of chronic myelomonocytic leukemia in Chinese patients
por: Nie, Yanbo, et al.
Publicado: (2022)

RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
por: Carr, Ryan M., et al.
Publicado: (2021)

Clinical and molecular features of CBL-mutated juvenile myelomonocytic leukemia
por: Yoshida, Taro, et al.
Publicado: (2023)

Eighty-year-old man with rare chronic neutrophilic leukemia caused by CSF3R T618I mutation: A case report and review of literature
por: Li, Ya-Ping, et al.
Publicado: (2020)

CSF3R T618I co-occurs with mutations of splicing and epigenetic genes and with a new PIM3 truncated fusion gene in chronic neutrophilic leukemia
por: Menezes, J, et al.
Publicado: (2013)

Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia
por: Adam, Franziska C., et al.
Publicado: (2022)

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
por: Niemeyer, Charlotte M., et al.
Publicado: (2010)

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance
por: Patnaik, M M, et al.
Publicado: (2016)

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
por: Lipka, Daniel B., et al.
Publicado: (2017)

P496: PHENOTYPIC SUBTYPES OF LEUKEMIC TRANSFORMATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA
por: Montalban-Bravo, Guillermo, et al.
Publicado: (2023)

EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
por: Patnaik, Mrinal M., et al.
Publicado: (2018)

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016)

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents
por: Duchmann, Matthieu, et al.
Publicado: (2018)

Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia
por: Kim, Hyun-Young, et al.
Publicado: (2018)

TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia
por: Quang, Violaine Tran, et al.
Publicado: (2023)

Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
por: Lin, Min, et al.
Publicado: (2023)

ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26
por: Perez Botero, J, et al.
Publicado: (2015)

Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for CSF3R T618I Mutant Chronic Neutrophilic Leukemia
por: Ye, Peipei, et al.
Publicado: (2023)

A novel mutation of SETBP1 in atypical chronic myeloid leukemia transformed from acute myelomonocytic leukemia
por: Hu, WangQiang, et al.
Publicado: (2015)

Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia
por: Faisal, Muhammad, et al.
Publicado: (2019)

Germline CSF3R Variant in Chronic Myelomonocytic Leukemia: Linking Genetic Predisposition to Uncommon Hemorrhagic Symptoms
por: Bochicchio, Maria Teresa, et al.
Publicado: (2023)

Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune Disorders
por: Dussiau, Charles, et al.
Publicado: (2023)

Acute Myeloid Leukemia with Co-mutated ASXL1 and SRSF2 Exhibits Monocytic Differentiation and has a Mutational Profile Overlapping with Chronic Myelomonocytic Leukemia
por: Johnson, Steven M., et al.
Publicado: (2019)

Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia
por: Dao, Kim-Hien T., et al.
Publicado: (2014)

Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis
por: Shou, Li-Hong, et al.
Publicado: (2017)

Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia
por: Okay, Müfide, et al.
Publicado: (2019)

The Genomic Landscape of Juvenile Myelomonocytic Leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2015)

Lysozyme nephropathy in chronic myelomonocytic leukemia
por: Patel, Ami B., et al.
Publicado: (2019)

Diagnosis and treatment of chronic myelomonocytic leukemia
por: Kwon, Jihyun
Publicado: (2021)

Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021)

Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report
por: Pelkey, Lauren J, et al.
Publicado: (2022)

Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival
por: Geissler, Klaus, et al.
Publicado: (2021)

TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia
por: Pérez, Cristina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b381i5um70ueekechcuv4r09dn